Cycloruthenated Self-Assembly with Metabolic Inhibition to Efficiently Overcome Multidrug Resistance in Cancers
Friday, March 31, 2023
2:00 pm - 3:00 pm
Multidrug resistance (MDR) represents a major obstacle to the treatment of cancer, and understanding the resistance mechanisms and knowing how to reverse the resistance hold the promise of providing insights that may lead to improvements in the use of currently available anticancer drugs. Dr. Chen will discuss the development of a simple, versatile and efficacious self-assembled cyclometalated complex, RuZ, to overcome MDR cancer cells.
Zhe-Sheng Chen, Professor, Director of the Institute for Biotechnology and a Special Advisor to the Provost for international students at St. John’s University. He is an expert in the field of multi-drug resistance (MDR) following chemotherapy, with the goal of his lab being the development of more effective anticancer drugs. His research interests range from basic to clinical studies on drug resistance in cancers.
- UH Technology Bridge, 5000 Gulf Freeway, Innovation Center, Building 4
Please direct any questions to: Nadine Peterson, DDI Coordinator at email@example.com.